ANI Pharmaceuticals | ANIP - Pre Tax Profit

Stock Price
81.84
Daily Change
0.34 0.42%
Monthly
2.98%
Yearly
35.16%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $49.52M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
AbbVie USD 4.38B 1.92B Sep/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Novartis USD 5.17B 637M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Sun Pharmaceuticals INR 41.68B 9.95B Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025